Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and GliomasKarl Holmberg Olausson(Dana-Farber Cancer Institute), Keith L. Ligon(Brigham and Women's Hospital)PLoS ONESeptember 3, 201410.1371/journal.pone.0106694Cited by 46SaveCiteExport RISWatch citationsRelated PapersPhase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02|Neuro-Oncology|2014|166Pten Loss in Olig2 Expressing Neural Progenitor Cells and Oligodendrocytes Leads to Interneuron Dysplasia and Leukodystrophy|Stem Cells|2013|29